期刊文献+

更昔洛韦儿童用药安全失效模式筛选及分析 被引量:6

Screening and Analysis of Safety Failure Modes of Ganciclovir in Pediatric Drug Therapy
原文传递
导出
摘要 目的分析更昔洛韦用药安全中的风险点,制定用药安全防范策略。方法利用失效模式与效果分析法,通过文献检索、问卷调查、实地考察等步骤,寻找更昔洛韦儿童用药过程中的失效模式。结果通过风险优先级数评分,共获5项需立即干预的更昔洛韦用药风险点,并针对这些风险点制定防范策略。结论更昔洛韦在儿科临床使用的各个环节仍有许多用药风险存在。我国关于儿童合理用药的法律、法规、部门规章、规定甚少,关于保障和促进儿童合理用药的政策有待落实和实施。 OBJECTIVE To analysis the risks of ganciclovir using in children, and to formulate security policy. METHODS The failure mode and effect analysis method were used to search for the failure modes of ganciclovir in pediatric drug therapy by literature searching, questionnaire survey, field investigation and other steps. RESULTS Five failure modes of ganciclovir in pediatric drug therapy were obtained through the risk priority score, and precautionary strategies were established for these failure modes. CONCLUSION There are still many risks of ganciclovir in all aspects of pediatric clinical use. In China, there are few laws on children's rational use of drugs.
作者 赵杰 张冠东 薛智民 杨钰 高燕飞 韩燕 赵瑞玲 ZHAO Jie;ZHANG Guandong;XUE Zhimin;YANG Yu;GAO Yanfei;HAN Yan;ZHAO Ruiling(Pharmacy Department, Children's Hosptial of Shanxi Provence, Taiyuan 030013, China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2018年第5期770-773,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 更昔洛韦 儿童 失效模式与效果分析 ganciclovir children failure modes and effects analysis
  • 相关文献

参考文献4

二级参考文献28

  • 1戚岳俊,佀传勇,何卫民,陈光辉.医院制剂和药品调剂的界定及管理初探[J].中国药事,2006,20(4):233-234. 被引量:4
  • 2邢冬青,李惠斌.对医疗机构药品使用管理的思考[J].中国药事,2006,20(7):395-396. 被引量:1
  • 3曹春林.中药药剂学.上海科学技术出版社,1993:2.
  • 4Anony. High-alert medications and patient safety[J]. Sen- tinel Event Alert, 1999,11 : 1.
  • 5The Joint Commission. High-Alert Medications and Pa- tient Safety[J/OL].http//www.jointcommission.org/sentine- levents/sentineleventalert/sea 11.htm. 1999-11.2008-11- 12.
  • 6Institute for Safe Medication Practices. 1SMP's List of Hi- gh-Alert Medications[EB/OL ]. http://www.ismp.org/Tools/ highalertmedications.pdf. 2008.2008-11-12.
  • 7王育琴,唐静.长春新碱误行鞘内注射引起的思考[EB/OL].http://www.jkb.com.cn/documentjsp?docid=27413.2007-12-04.20l1-05-02.
  • 8High-alert medications and patient safety[J/OL]. The Jointcommission, 1999 ( 11 ). [ 2008-11-12 ].http//www.jointcommission.org/sentinelevents/sen- tineleventalert/sea_l 1.htm.
  • 9黄邱敏,刘琼芳,操银针.病区高危药品的规范化管理[J].中国临床护理,2009,1(1):7-8. 被引量:18
  • 10张波,梅丹.医院高危药物管理和风险防范[J].中国药学杂志,2009,44(1):3-6. 被引量:118

共引文献119

同被引文献67

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部